Food Effect and Multiple-Dose Study of Chiglitazar/Metformin Extended-Release Tablets

Clinical trial NCT07511010 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07511010
Sponsor: Chipscreen Biosciences, Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

T2DM (Type 2 Diabetes Mellitus)

Start date: 2026-10-08
Primary completion: 2026-10-26
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.